Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reliant Glycosciences
Birmingham, Alabama, United States
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Reliant Glycosciences has developed and validated proprietary clinical-grade biomarker assays (GalD Assay and IgG-AA assay) that detect and quantify disease-specific markers for IgA nephropathy, showing promising sensitivity and reproducibility in internal and external validation studies[7].
- Therapeutic areas
- Nephrology
- Modalities
- Diagnostic assay
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
University of Alabama at Birmingham
Beyond the preview
Go deeper on Reliant Glycosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reliant Glycosciences.